All
Taming Cancer's Beasts One Treatment at a Time
January 2nd 2019Making peace with radiation can be a challenge, even if high doses of targeted radiation can silence cancer cells. It took me almost two weeks to tame the beast of fear. What have you done to trick yourself into handling difficult situations during cancer treatment?
Investigational BTK Inhibitor Sparks Responses in Patients with Mantle Cell Lymphoma
December 26th 2018The investigational targeted drug zanubrutinib (BGB-3111) appeared to be highly active, inducing an overall response rate of 83.5 percent in patients with relapsed/refractory mantle cell lymphoma, who were treated in a single-arm, open-label, multicenter, phase 2 trial.